The Effects of Low Dose Naltrexone (LDN) on Diseases of Aging

Withdrawn before enrolling

Conditions studied: Aging

In brief

This retrospective, observational study will assess the health status of short- and long-term low-dose naltrexone (LDN) users.

Key facts

Study ID

NCT05307627

Run by

AgelessRx

People needed

0

Starts

2022-03-14

Expected to finish

2023-12-14

Last updated by the study team

2024-08-06

Who can join

Age: 18 and older, up to 120. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adults (aged 18-120)
• Any sex
• Any ethnicity
• Taking LDN
• Willing to complete health questionnaires
• Technologically competent to complete web forms
• Subgroup: willing to undergo blood testing

You may not qualify if…

• LDN doses over 20 mg/day
• Terminal cancer patients (defined as stage IV and/or with a life expectancy of 12 months or less)

Where it is running

• AgelessRx — Ann Arbor, Michigan, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.